Literature DB >> 11030712

Adenosine A(1) receptor stimulation inhibits alpha(1)-adrenergic activation of the cardiac sarcolemmal Na(+)/H(+) exchanger.

M Avkiran1, H Yokoyama.   

Abstract

Sarcolemmal Na(+)/H(+) exchanger (NHE) activity is increased by stimulation of G(q) protein-coupled receptors (G(q)PCRs), but the roles of other GPCRs are largely unknown. We determined the effects of N-[(1S,trans)-2-hydroxycyclopentyl]adenosine (GR79236), a selective agonist of the G(i)PCR adenosine A(1) receptor, on sarcolemmal NHE activity in adult rat ventricular myocytes (n=8-10 per group). NHE activity was indexed by the H(+) efflux rate after intracellular acidification, measured by microepifluorescence. GR79236 alone (0.01-10 microM) had no effect on NHE activity. However, co-administration of GR79236 inhibited, in a concentration-dependent manner, the stimulation of NHE activity by the alpha(1)-adrenoceptor agonist phenylephrine (10 microM). The inhibitory effect of GR79236 (10 microM) was abolished by (1) the selective A(1) antagonist 1,3-dipropyl-8-cyclopentylxanthine (0.1 microM), confirming an A(1) receptor-mediated action, and (2) pre-treatment with pertussis toxin (5 microgram ml(-1) for 60 min), indicating a G(i) protein-mediated mechanism. Our data suggest the existence of inhibitory crosstalk between the G(i)PCR adenosine A(1) receptor and the G(q)PCR alpha(1)-adrenoceptor in the regulation of sarcolemmal NHE activity.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11030712      PMCID: PMC1572400          DOI: 10.1038/sj.bjp.0703647

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  18 in total

1.  Alpha1-adrenergic stimulation of sarcolemmal Na+-H+ exchanger activity in rat ventricular myocytes: evidence for selective mediation by the alpha1A-adrenoceptor subtype.

Authors:  H Yokoyama; M Yasutake; M Avkiran
Journal:  Circ Res       Date:  1998-06-01       Impact factor: 17.367

2.  Adenosine as an adjunct to thrombolytic therapy for acute myocardial infarction: results of a multicenter, randomized, placebo-controlled trial: the Acute Myocardial Infarction STudy of ADenosine (AMISTAD) trial.

Authors:  K W Mahaffey; J A Puma; N A Barbagelata; M F DiCarli; M A Leesar; K F Browne; P R Eisenberg; R Bolli; A C Casas; V Molina-Viamonte; C Orlandi; R Blevins; R J Gibbons; R M Califf; C B Granger
Journal:  J Am Coll Cardiol       Date:  1999-11-15       Impact factor: 24.094

Review 3.  Molecular biology of the cardiac sodium/hydrogen exchanger.

Authors:  L Fliegel; J R Dyck
Journal:  Cardiovasc Res       Date:  1995-02       Impact factor: 10.787

4.  Roles of mitogen-activated protein kinases and protein kinase C in alpha(1A)-adrenoceptor-mediated stimulation of the sarcolemmal Na(+)-H(+) exchanger.

Authors:  A K Snabaitis; H Yokoyama; M Avkiran
Journal:  Circ Res       Date:  2000-02-04       Impact factor: 17.367

5.  Inhibition of the sodium-hydrogen exchanger with cariporide to prevent myocardial infarction in high-risk ischemic situations. Main results of the GUARDIAN trial. Guard during ischemia against necrosis (GUARDIAN) Investigators.

Authors:  P Théroux; B R Chaitman; N Danchin; L Erhardt; T Meinertz; J S Schroeder; G Tognoni; H D White; J T Willerson; A Jessel
Journal:  Circulation       Date:  2000-12-19       Impact factor: 29.690

Review 6.  Rational basis for use of sodium-hydrogen exchange inhibitors in myocardial ischemia.

Authors:  M Avkiran
Journal:  Am J Cardiol       Date:  1999-05-20       Impact factor: 2.778

7.  Cardioprotective effects of the Na(+)/H(+) exchange inhibitor cariporide in patients with acute anterior myocardial infarction undergoing direct PTCA.

Authors:  H J Rupprecht; J vom Dahl; W Terres; K M Seyfarth; G Richardt; H P Schultheibeta; M Buerke; F H Sheehan; H Drexler
Journal:  Circulation       Date:  2000-06-27       Impact factor: 29.690

8.  Adenosine A(1) receptor stimulation inhibits alpha(1)-adrenergic activation of the cardiac sarcolemmal Na(+)/H(+) exchanger.

Authors:  M Avkiran; H Yokoyama
Journal:  Br J Pharmacol       Date:  2000-10       Impact factor: 8.739

9.  Thrombin activates the sarcolemmal Na(+)-H+ exchanger. Evidence for a receptor-mediated mechanism involving protein kinase C.

Authors:  M Yasutake; R S Haworth; A King; M Avkiran
Journal:  Circ Res       Date:  1996-10       Impact factor: 17.367

10.  Functional characterization of three adenosine receptor types.

Authors:  M F Gurden; J Coates; F Ellis; B Evans; M Foster; E Hornby; I Kennedy; D P Martin; P Strong; C J Vardey
Journal:  Br J Pharmacol       Date:  1993-07       Impact factor: 8.739

View more
  6 in total

Review 1.  Cardiac purinergic signalling in health and disease.

Authors:  Geoffrey Burnstock; Amir Pelleg
Journal:  Purinergic Signal       Date:  2014-12-20       Impact factor: 3.765

2.  Effects of moderate hypothermia on sarcolemmal Na(+)/H(+) exchanger activity and its inhibition by cariporide in cardiac ventricular myocytes.

Authors:  K Hoshino; M Avkiran
Journal:  Br J Pharmacol       Date:  2001-12       Impact factor: 8.739

3.  AICAR inhibits the Na+/H+ exchanger in rat hearts--possible contribution to cardioprotection.

Authors:  Terence R Moopanar; Xiao-Hui Xiao; Lele Jiang; Zhi-Ping Chen; Bruce E Kemp; David G Allen
Journal:  Pflugers Arch       Date:  2006-09-16       Impact factor: 3.657

4.  Adenosine A(1) receptor stimulation inhibits alpha(1)-adrenergic activation of the cardiac sarcolemmal Na(+)/H(+) exchanger.

Authors:  M Avkiran; H Yokoyama
Journal:  Br J Pharmacol       Date:  2000-10       Impact factor: 8.739

Review 5.  NHE-1 inhibition: from protection during acute ischaemia/reperfusion to prevention/reversal of myocardial remodelling.

Authors:  Wolfgang J Linz; Andreas E Busch
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-09-19       Impact factor: 3.000

6.  Cardioprotective efficacy of zoniporide, a potent and selective inhibitor of Na+/H+ exchanger isoform 1, in an experimental model of cardiopulmonary bypass.

Authors:  Hugh Clements-Jewery; Fiona J Sutherland; Mary C Allen; W Ross Tracey; Metin Avkiran
Journal:  Br J Pharmacol       Date:  2004-03-22       Impact factor: 8.739

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.